Pfizer's surveillance website and app help fight antimicrobial resistance

Pfizer has launched a website and app to help fight antimicrobial resistance.

The Antimicrobial Testing Leadership and Surveillance (ATLAS) website is designed to provide doctors and the global healthcare community with easy access to critical data on the efficacy of various antibiotic treatments and emerging resistance patterns across more than 60 countries.

Understanding evolving bacterial resistance patterns is a key element in managing the rise of antimicrobial resistance. ATLAS can help doctors select the most appropriate treatment choices for their patients, and can also enable global health authorities to develop data-driven antimicrobial resistance mitigation strategies.

Pfizer formally unveiled ATLAS last month at the annual meeting of the European Congress of Clinical Microbiology and Infectious Disease (ECCMID) in Vienna.

“An important aspect for physicians when treating patients is knowledge; knowledge of where certain resistant bacterial infections tend to occur and knowledge of which antibiotics remain effective against them,” said Dr Freda Lewis-Hall, chief medical officer of Pfizer.

“ATLAS underscores our continued commitment to providing patients and physicians with meaningful resources that can help ensure appropriate utilisation of antibiotics and improve infection prevention and control.”